Blue Horseshoe Stocks

Blue Horseshoe Stocks: News Plays & Special Reminder

Aeterna Zentaris, Inc. AEZS

AEZS is gapping up this morning on the heels of some news. It’s been quite a few months since we last mentioned this stock. That was back in the fall, and we subsequently witnessed quite a surge from the stock after that.

Since then, so far in 2017 the stock has come down to record new annual lows, and recently has been making incremental increases off of that bottom. In light of today’s news, described below, we think it’s a good time to put AEZS back on a more intensive watch.

The company announced this morning, following a comprehensive review Phase 3 clinical data on Macrilen™ for the evaluation of growth hormone deficiency, that Macrilen™ demonstrated performance supportive of achieving registration with the FDA. The FDA has agreed to consider the Company’s conclusions during a Type A meeting, which is currently being scheduled. (>>View PR)

Zosano Pharma Corp. ZSAN

Speaking of fresh news plays, we also want to highlight the announcement coming from ZSAN this morning that presently has the stock gapping up in the premarket to the tune of 50%

This morning ZSAN reported that in its ZOTRIP pivotal efficacy study, the company’s M207 transdermal migraine therapy patch met both primary, as well as secondary endpoints. It certainly explains the premarket hoopla, and warrants our observation as we kick off a new trading week.

The chart also has some attractive features which we’ve pointed out on the snapshot below:

**SPECIAL REMINDER**

To wrap things up this morning, we want to leave our readers with a quick heads up on a big Tuesday coming up. We’ve got a special report coming out tomorrow prior to the opening bell. It could represent quite an opportunity, so tomorrow is definitely not the day to miss out on our premarket report!

Be sure to stay locked onto your email inboxes or BlueHorseshoeStocks.com tomorrow between 9:00 to 9:15AM, and lean on those refresh buttons!

Extended Watchlist:
MCIG, MYHI, ADVT, MJTK, QSIM, NK

Blue Horseshoe Stocks: Options, Bottom Bouncer & More

Galectin Therapeutics, Inc. GALT

This morning we’re taking a look back at GALT, which we highlighted as a ripening play that we felt was worthy of observation last month.

Our suspicion that the chart had growth in store turned out to be correct. Since we put this play on our radar it has gone on to trade in a solid range from .935 to 1.29, which works out to an increase of 38%

We feel these gains are sustainable if GALT can manage to crack past the current 200DMA at 1.32. As you can see on the included snapshot, the chart continues to bear the look of potential for even further increases, so we’ll stay on the lookout for that.

Whole Foods Market, Inc. WFM

WFM is showing some nice volatility and positive price action despite a fairly uninteresting earnings release this week.

We like to follow the activity regardless, and today it’s leading us to focus on some WFM options. Rather than selecting weekly options that will expire this afternoon, we’ll go out to contracts that expire next Friday; the WFM 02/17 $30 & $30.50 Calls.

NantKwest, Inc. NK – Bottom-Bouncer

The NK chart gave off a pretty good bottom-bounce signal yesterday and the day before, so we’ll be interested in tracking the action in this play over the next several sessions on the chance that it can string together a multi-session uptrend.

From the chart below, it’s easy to see why we feel NK could be ripe for the picking. The RSI is increasing, while the MACD is a hair’s breath away from a bullish cross that generally indicates some significant move to the upside is in the stock’s near future. We’ll have our eyes peeled for that.

Extended Watchlist:
MYHI, ICNB, INCC, SPDL, UAMM, ICPT

Blue Horseshoe Stocks: Potential Bottom-Plays & More

Bottom-Watch Plays

We want to start things off this morning by highlighting a couple of stocks on the higher exchanges that are both currently trading at a low multiple. Stocks that trade on the NASDAQ and NYSE at less than a dollar per share for at least a month can face de-listing procedures, so companies in danger of this tend to go to great lengths to buoy their stock price.

We’re always on the lookout for possible bottom plays so we’re going to be tracking both of the following in coming sessions.

Cobalt International Energy, Inc. CIE – The de-listing alarm bells haven’t quite gone off yet at with CIE, as the PPS just fell below a buck toward the end of last month. The stock also has a recent track record of brief periods of sub-1.00 trading from which it has promptly recovered each time.

This leads us to believe that the company may not even get to the point of receiving a notice from the NYSE before share price sees a recovery. We’re going to want to be on the lookout for that potential rebound.

______

Alliqua Biomedical, Inc. ALQA – In the case of ALQA, a NASDAQ play, the situation is a bit more pressing. Shares fell below the dollar mark at the beginning of September, and the company did receive its ‘failure to satisfy listing requirement’ notice back in October. The PPS has lagged ever since, and has only until the end of April to re-attain the dollar mark, or face delisting.

We’ll be interested to follow along to see what efforts are untaken to once again satisfy listing requirements. In the meantime, the stock has found a reasonably solid base of support off of recent lows, so we’ll be on the lookout for possible rebounds.

Viacom, Inc. VIAB – Options Idea

Our regular readers know full well that we love a good earnings-related options idea, and that’s what we’ve got this morning with Viacom. The company just posted an impressive earnings beat, along with strategic guidance updates that has the stock rocking in the premarket.

We’re going to be keeping our eyes open upon the opening bell, and tracking the activity in the VIAB Weekly $44-45.50 Calls.

Extended Watchlist:
MMEG, SDVI, ISBG, ETRM, CLF, TSLA,

Blue Horseshoe Stocks: MYOS Recap, Gold Plays & More

MYOS RENS Technology, Inc. MYOS

Easily the most solid performer that was discussed in yesterday morning’s premarket report, MYOS stole the show with everything we look for in a daily runner- an early burst that gives traders a chance at some nice intraday gains, high volume, and maintaining a good portion of the gains it makes into the close.

MYOS checked all three of those boxes yesterday, running early from its daily low of 3.61 up to a high of 5.48, which worked out to a nice 52% pop. MYOS closed at 4.72, maintaining over half of its daily advance, and did so on well over eight times the monthly average trading volume.

An all around performance like that certainly earns MYOS a continued slot on our radar screens in sessions ahead.

VanEck Vectors Gold Miners ETF (GDX)

With gold being so solid in the month of February, and indeed for most of 2017 so far, we want to rehash the idea we put forth on some GDX options and update our readers on their performance.

We initially signaled the GDX 02/10 $24-25.50 Calls in our report from January 23rd. Now set to expire on Friday, we wanted to circle back and remind our members of the kind of gains that could have been secured with this idea.

Here’s what they’ve done so far, and with gold continuing its climb, we can’t rule out seeing these upward trading range extended even further between now and the end of the week:

$24 Calls – Range: .32-1.46 – Max Gain: 356%
$24.50 Calls – Range: .19-1.05 – Max Gain: 453%
$25 Calls – Range: .11-.67 – Max Gain: 509%
$25.50 Calls – Range: .06-.39 – Max Gain: 550%

_________

Direxion Daily Gold Miners Bull 3X ETF (NUGT) – Another gold analog we’ve got a history with is NUGT, so we’re also going to highlight some contracts that have some potential here as well. Being a triple-leveraged fund, the activity in NUGT resembles that of GDX, but the magnitude of the percentage gains it has made on its chart over the same period are notably higher.

Should the massive gold rally maintain its trend, we could be looking at some serious moves in the NUGT Weekly $13-14 Calls, so that’s where we’ll set our sights with this one.

Extended Watchlist:
BTSC, NWPN, SOUM, SDVI, FNHI, CTSH

Blue Horseshoe Stocks: VDRM, ABVG & More

ViaDerma, Inc. VDRM

VDRM was the first of a pair of plays from yesterday morning’s extended watchlist. The stock enjoyed a gradually increased PPS over the course of the entire session, and ran into the closing bell with strength.

VDRM’s daily trading range was from .0145 to .03, which works out to an intraday pop of 107% The double-bag move came on well over twice the 3-month average volume, and as stated above, VDRM ran into the close, so we’re going to be maintaining our watch over the stock for the time being, looking for it to record higher lows and higher highs once again.

Affinity Beverage Group, Inc. ABVG

The other item of interest from yesterday’s premarket watchlist was ABVG, which also commanded a fantastic performance which led to a doubling in PPS.

ABVG ran a cool 100% from its super-subpenny low of .0007 right up to a subpenny high of .0014. Like the aforementioned play, it closed very near to its high-of-day, and did so on immense volume. To be exact, ABVG traded 13 times as many shares as its 3-month average, so we will also have room on our watchscreens for this one in sessions ahead.

Michael Kors Holdings Ltd. KORS – Options Idea

With KORS disappointing on Q3 revenue, as well as issuing shaky guidance, the stock is taking a hit in early trading here in the premarket.

Accordingly, we are going to want to signal a range of bearish options to monitor in the event that an even more precipitous decline is in the cards. We’ll be watching the KORS Weekly $39-36 Puts closely, and choosing our specific strike point/s based upon how the activity unfolds once these earnings revelations are traded upon during regular hours.

Extended Watchlist:
BIEL, TPNI, PULM, ATHX, MYOS, AVXL,